+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asthma Therapeutics Market Report by Drug Class, Product Type, Treatment Type, Route of Administration, and Region 2024-2032

  • PDF Icon

    Report

  • 141 Pages
  • August 2024
  • Region: Global
  • IMARC Group
  • ID: 5642332
Description Jump to:
The global asthma therapeutics market size reached US$ 18 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 22.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.25% during 2023-2032.

Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.

Asthma Therapeutics Market Trends:

The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines.

The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the global asthma therapeutics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on drug class, product type, treatment type and route of administration.

Breakup by Drug Class:

  • Anti-Inflammatory Drugs
  • Bronchodilators
  • Combination Therapies

Breakup by Product Type:

  • Inhalers
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Soft Mist Inhalers
  • Nebulizers
  • Pneumatic Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

Breakup by Treatment Type:

  • Quick-Relief Medications
  • Long-Term Asthma Control Medications

Breakup by Route of Administration:

  • Inhalation
  • Oral
  • Parenteral

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca PLC, Abbott Laboratories, Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Novartis International AG, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. What was the size of the global asthma therapeutics market in 2023?
2. What is the expected growth rate of the global asthma therapeutics market during 2024-2032?
3. What are the key factors driving the global asthma therapeutics market?
4. What has been the impact of COVID-19 on the global asthma therapeutics market?
5. What is the breakup of the global asthma therapeutics market based on the drug class?
6. What is the breakup of the global asthma therapeutics market based on the product type?
7. What is the breakup of the global asthma therapeutics market based on the treatment type?
8. What is the breakup of the global asthma therapeutics market based on the route of administration?
9. What are the key regions in the global asthma therapeutics market?
10. Who are the key players/companies in the global asthma therapeutics market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Asthma Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Anti-Inflammatory Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Bronchodilators
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Combination Therapies
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Product Type
7.1 Inhalers
7.1.1 Market Trends
7.1.2 Major Types
7.1.2.1 Dry Powder Inhalers
7.1.2.2 Metered Dose Inhalers
7.1.2.3 Soft Mist Inhalers
7.1.3 Market Forecast
7.2 Nebulizers
7.2.1 Market Trends
7.2.2 Major Types
7.2.2.1 Pneumatic Nebulizers
7.2.2.2 Ultrasonic Nebulizers
7.2.2.3 Mesh Nebulizers
7.2.3 Market Forecast
8 Market Breakup by Treatment Type
8.1 Quick-Relief Medications
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Long-Term Asthma Control Medications
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Inhalation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Parenteral
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AstraZeneca PLC
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Abbott Laboratories
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Amgen Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Biogen Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Boehringer Ingelheim International GmbH
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 F. Hoffmann-La Roche Ltd.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 GlaxoSmithKline Plc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Merck Sharp & Dohme Corp.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Novartis International AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sunovion Pharmaceuticals Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 SWOT Analysis
15.3.11 Teva Pharmaceutical Industries Ltd.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2023
Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2023
Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2023
Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2023
Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2023
Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Asthma Therapeutics (Combination Therapies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Asthma Therapeutics (Combination Therapies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
Figure 79: Global: Asthma Therapeutics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Asthma Therapeutics Market Structure
Table 8: Global: Asthma Therapeutics Market: Key Players

Companies Mentioned

  • AstraZeneca PLC
  • Abbott Laboratories
  • Amgen Inc.
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck Sharp & Dohme Corp.
  • Novartis International AG
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages141
PublishedAugust 2024
Forecast Period2023 - 2032
Estimated Market Value ( USD ) in 2023 $ 18 Billion
Forecasted Market Value ( USD ) by 2032 $ 22 Billion
Compound Annual Growth Rate2.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Asthma Therapeutics - Global Strategic Business Report - Product Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Asthma Therapeutics Market by Product, Drug Class, Route of administration - Global Forecast 2025-2030 - Product Image

Asthma Therapeutics Market by Product, Drug Class, Route of administration - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Asthma Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Asthma Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Allergic Asthma Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology - Product Image

Allergic Asthma Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

  • Report
  • 90 Pages
  • Global
From
Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.